Pfizer asks US regulators to authorize experimental COVID-19 pill
Fox News
Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home. COR
Pfizer’s pill has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections. The Food and Drug Administration is already reviewing a competing pill from Merck, and several smaller drugmakers are also expected to seek authorization for their own antiviral pills in the coming months.
"We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application," said Pfizer CEO Albert Bourla in a statement.